Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)
NCT01418430 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2011-08-22
Summary
The purpose of this study is to determine the safety of the combination of CHOP plus daclizumab in patients with ATLL previously untreated with anthracycline based chemotherapy.
Conditions
- HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)
Interventions
- DRUG
-
CHOP-daclizumab
Sponsors & Collaborators
-
King's College Hospital NHS Trust
lead OTHER
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)
NCT00145002 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.
NCT00429065 ·Status: UNKNOWN
-
Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma
NCT01290120 ·Status: COMPLETED ·Phase: PHASE2
-
Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
NCT00794820 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL
NCT00441025 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
NCT00086203 ·Status: COMPLETED ·Phase: PHASE2
-
Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL)
NCT06347653 ·Status: RECRUITING ·Phase: PHASE2
-
A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)
NCT03292406 ·Status: COMPLETED ·Phase: PHASE2
-
CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma
NCT01806337 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
NCT00053092 ·Status: COMPLETED ·Phase: PHASE2
-
Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients
NCT00050999 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
NCT01539512 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland
NCT03582098 ·Status: COMPLETED
-
Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
NCT03631862 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
NCT00641095 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL)
NCT03571308 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients
NCT00051012 ·Status: COMPLETED ·Phase: PHASE4
-
Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-cell Lymphoma
NCT00386321 ·Status: TERMINATED ·Phase: PHASE2
-
The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)
NCT00930605 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.
NCT00532129 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
NCT00049413 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)
NCT00309881 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma
NCT02285062 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion
NCT02044822 ·Status: TERMINATED ·Phase: PHASE2
-
Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies
NCT00072514 ·Status: COMPLETED ·Phase: PHASE2